Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2008-5-1
pubmed:abstractText
Anti-sigma factors Escherichia coli Rsd and bacteriophage T4 AsiA bind to the essential housekeeping sigma factor, sigma(70), of E. coli. Though both factors are known to interact with the C-terminal region of sigma(70), the physiological consequences of these interactions are very different. This study was undertaken for the purpose of deciphering the mechanisms by which E. coli Rsd and bacteriophage T4 AsiA inhibit or modulate the activity of E. coli RNA polymerase, which leads to the inhibition of E. coli cell growth to different amounts. It was found that AsiA is the more potent inhibitor of in vivo transcription and thus causes higher inhibition of E. coli cell growth. Measurements of affinity constants by surface plasmon resonance experiments showed that Rsd and AsiA bind to sigma(70) with similar affinity. Data obtained from in vivo and in vitro binding experiments clearly demonstrated that the major difference between AsiA and Rsd is the ability of AsiA to form a stable ternary complex with RNA polymerase. The binding patterns of AsiA and Rsd with sigma(70) studied by using the yeast two-hybrid system revealed that region 4 of sigma(70) is involved in binding to both of these anti-sigma factors; however, Rsd interacts with other regions of sigma(70) as well. Taken together, these results suggest that the higher inhibition of E. coli growth by AsiA expression is probably due to the ability of the AsiA protein to trap the holoenzyme RNA polymerase rather than its higher binding affinity to sigma(70).
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-10322161, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-10482532, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-11237608, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-11243776, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-11292818, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-11591686, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-12242019, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-12270815, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-12718891, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-14687566, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-14962387, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-15068809, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-15257291, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-15294015, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-15561138, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-16545925, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-16567622, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-17021309, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-17351046, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-17681541, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-7565101, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-7744235, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-7877999, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-8253389, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-8416914, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-8824593, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-9560209, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-9765212, http://linkedlifedata.com/resource/pubmed/commentcorrection/18359804-9891799
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1098-5530
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
190
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3434-43
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Differential mechanisms of binding of anti-sigma factors Escherichia coli Rsd and bacteriophage T4 AsiA to E. coli RNA polymerase lead to diverse physiological consequences.
pubmed:affiliation
AstraZeneca R & D, Bellary road, Hebbal, Bangalore, India. umender.sharma@astrazeneca.com
pubmed:publicationType
Journal Article